GlobeImmune files for IPO
Louisville, Colorado-based GlobeImmune, the developer of biopharmaceuticals aimed at treating cancer and infectious diseases, filed for an IPO Tuesday, saying it is looking to raise up to $69M on the NASDAQ Global Market.
The Naftohaz Ukrainy national joint-stock company intends to hold IPO in 2012-2013, chairman of the national joint-stock company Yevhen Bakulin told the press.